Physician profile
Kevin Smith
NPI 1205898137
$6,458.25
in general payments reported to CMS, 2019-2025
38 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,087 · 2020: $842 · 2021: $327 · 2022: $168 · 2023: $1,248 · 2024: $1,607 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,035.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,316.51 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $756.69 | 2019-2024 | Senza |
| Medtronic, INC. | $691.17 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Stimwave Technologies Incorporated | $599.71 | 2019-2020 | |
| Spr Therapeutics, INC | $266.96 | 2019-2024 | Sprint Pns System |
| Nalu Medical, INC. | $241.98 | 2023-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $230.44 | 2019-2024 | Belbuca, Xtampza |
| Abbvie INC. | $230.32 | 2023-2025 | Ubrelvy, Qulipta |
| Abbott Laboratories | $199.10 | 2020-2024 | Eterna |
| Pacira Therapeutics, INC. | $166.19 | 2019 | |
| Relievant Medsystems, INC. | $162.07 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $143.66 | 2019-2022 | |
| Mml US, INC. | $121.80 | 2023 | Reactiv8 |
| Painteq LLC | $113.92 | 2022-2024 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.63 | 2020-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $109.62 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $80.86 | 2019-2020 | |
| Pfizer INC. | $79.99 | 2019 | |
| Allergan, INC. | $78.41 | 2019-2020 | |
| Medtronic USA, INC. | $75.35 | 2019 | |
| Amgen INC. | $74.25 | 2019-2020 | |
| Avanos Medical | $72.83 | 2019 | |
| Assertio Therapeutics, INC. | $60.53 | 2019 | |
| Biodelivery Sciences International, INC. | $59.19 | 2019-2020 | |
| Saluda Medical Americas, INC. | $56.16 | 2023-2025 | Evoke Scs, Evoke |
| Merck Sharp & Dohme LLC | $53.79 | 2020-2025 | Bridion |
| Teva Pharmaceuticals USA, INC. | $44.18 | 2019-2020 | |
| Baxter Healthcare | $41.51 | 2025 | Perclot |
| Bioventus LLC | $38.13 | 2019-2020 | |
| Si-Bone, INC. | $36.39 | 2019-2024 | |
| Arbor Pharmaceuticals, INC. | $24.81 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $20.88 | 2020 | |
| Avanir Pharmaceuticals, INC. | $18.35 | 2019 | |
| Becton, Dickinson and Company | $17.89 | 2025 | Hemosphere |
| Almatica Pharma LLC | $16.93 | 2022 | |
| Sentynl Therapeutics, INC. | $15.77 | 2019 | |
| Kaleo, INC. | $15.57 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.